Expertise in
1
conditions

Jeroen S. Goede

Winterthur, ZH, CH 
Expertise in
1
conditions
Winterthur, ZH, CH 

Overview

Jeroen Goede practices practicing medicine in Winterthur, Switzerland.

Mr. Goede is highly rated in 1 condition, according to our data. His clinical expertise encompasses Anemia, Hemolytic Anemia, Myelodysplastic Syndrome (MDS), Panhypopituitarism, and Splenectomy.

He is actively involved in clinical research, co-authoring 50 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Winterthur, ZH 8401, Switzerland
Other Locations
Zurich, ZH 8057, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia. A Multicenter, Open-label, Phase II Trial
Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia. A Multicenter, Open-label, Phase II Trial
Enrollment Status: Terminated
Publish Date: December 30, 2025
Intervention Type: Drug
Study Drugs: Ibrutinib, Venetoclax
Study Phase: Phase 2
Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma. A Multi-center, Single Arm Phase II Trial
Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma. A Multi-center, Single Arm Phase II Trial
Enrollment Status: Terminated
Publish Date: June 10, 2021
Intervention Type: Drug
Study Drugs: Pomalidomide, Dexamethasone
Study Phase: Phase 2
View 1 Less Clinical Trial

50 Total Publications

Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 31, 2026

Frequently Asked Questions about Jeroen S. Goede

Is Jeroen S. Goede a top-rated expert for Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Jeroen S. Goede is classified as an Advanced expert for Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jeroen S. Goede participate in research or clinical trials?

Yes. Jeroen S. Goede has published 50 articles and abstracts on conditions like Anemia. You can view a list of Jeroen S. Goede's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Goede's expertise for a condition
ConditionClose
      View All 31 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile